NCT03614949 2026-04-01
SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Active not recruiting
H. Lee Moffitt Cancer Center and Research Institute
Boston Scientific Corporation
H. Lee Moffitt Cancer Center and Research Institute
University of California, San Diego
Chongqing University Cancer Hospital